Imunopharm Technology Co., Ltd.
- Biotech or pharma, therapeutic R&D
IMUNOPHARM is a leading clinical-stage CGT biopharmaceutical company founded in Beijing.
It's striving to discover and develop cell and gene therapies for the patients with hematological malignancies, solid tumors and autoimmune diseases globally. We have developed a robust CAR-T pipeline supported by fully integrated R&D, CMC and clinical platforms. We have 10 CAR-T candidates in the pipeline with 8 IND approvals obtained and 1 potential NDA clearance from China NMPA and US FDA with 10 registrational clinical trials completed or ongoing.
IMUNOPHARM owns the state-of-the-art cGMP manufacturing facility granted as the 1st holder of Drug Production License for gene and cell drugs in Beijing and certificated through NMPA IND. Meanwhile, the Automatic Fully-enclosed Cell Processing System is under development with our strategic partner. These will fully support the manufacturing and supply strategies of CAR-T cell therapy with low cost, high efficiency and territory flexibility.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}